Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Fumagalli P"'
Autor:
Lucie Houdou, MD, Claire Meynard, MD, Sophie Guillerm, MD, Camille Mimoun, MD, Tiphaine Lambert, MD, Eva Marchand, MD, Diane Jornet, MD, Ingrid Fumagalli, MD, Laurent Quero, MD, PhD, Cyrille Huchon, MD, PhD, Christophe Hennequin, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 7, Pp 101512- (2024)
Purpose: This study aims to assess the feasibility and efficacy of high-dose rate (HDR) brachytherapy (BT) administered in a single insertion with 4 treatment sessions for locally advanced cervical cancer and to identify the prognostic factors influe
Externí odkaz:
https://doaj.org/article/de75e59709d84b4080d5e2e9e0d8cae8
Autor:
Lorenzo Gervaso, Davide Ciardiello, Giuliana Gregato, Lorenzo Guidi, Carmine Valenza, Liliana Ascione, Laura Boldrini, Samuele Frassoni, Chiara Alessandra Cella, Francesca Spada, Luigi Funicelli, Giuseppe De Roberto, Wanda Petz, Simona Borin, Marianna Alessandra Gerardi, Luca Bottiglieri, Darina Tamayo, Emilio Bertani, Uberto Fumagalli Romario, Vincenzo Bagnardi, Giuseppe Curigliano, Francesco Bertolini, Nicola Fazio, Maria Giulia Zampino
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: The management of locally advanced rectal cancer (LARC) relies on a multimodal approach. Neither instrumental work-up nor molecular biomarkers are currently available to identify a risk-adapted strategy. Objectives: We aim to investigate
Externí odkaz:
https://doaj.org/article/9f9c536bccb54df2b69506298ebbd4a9
Autor:
Júlia Teixeira de Menezes, Maria Carolina Theisen, Vanessa da Costa Flores, Fernando Fumagalli
Publikováno v:
Revista Brasileira de Cancerologia, Vol 70, Iss 1 (2024)
Introdução: Os anticorpos monoclonais (mAb) são alternativa terapêutica importante no tratamento do câncer. Porém, o acesso a essa terapia é desigual entre países com diferentes rendas. Objetivo: Comparar os fármacos mAb aprovados para uso c
Externí odkaz:
https://doaj.org/article/c5a8a7c837b34502b7d4282bcdb2a2b2
Autor:
Mariagiulia Dal Cero, Joan Gibert, Luis Grande, Marta Gimeno, Javier Osorio, Maria Bencivenga, Uberto Fumagalli Romario, Riccardo Rosati, Paolo Morgagni, Suzanne Gisbertz, Wojciech P. Polkowski, Lucio Lara Santos, Piotr Kołodziejczyk, Wojciech Kielan, Rossella Reddavid, Johanna W. van Sandick, Gian Luca Baiocchi, Ines Gockel, Andrew Davies, Bas P. L. Wijnhoven, Daniel Reim, Paulo Costa, William H. Allum, Guillaume Piessen, John V. Reynolds, Stefan P. Mönig, Paul M. Schneider, Elisenda Garsot, Emma Eizaguirre, Mònica Miró, Sandra Castro, Coro Miranda, Xavier Monzonis-Hernández, Manuel Pera, on behalf of the Spanish EURECCA Esophagogastric Cancer Group and the European GASTRODATA Study Group
Publikováno v:
Cancers, Vol 16, Iss 13, p 2463 (2024)
Background: Radical gastrectomy remains the main treatment for gastric cancer, despite its high mortality. A clinical predictive model of 90-day mortality (90DM) risk after gastric cancer surgery based on the Spanish EURECCA registry database was dev
Externí odkaz:
https://doaj.org/article/512cdc1d1ebd4fa3956cf82f6ec8f73c
Autor:
Giuseppe Marino, Tommaso Grassi, Elena De Ponti, Serena Negri, Filippo Testa, Daniela Giuliani, Martina Delle Marchette, Cristina Dell’Oro, Diletta Fumagalli, Gianluca Donatiello, Giulia Besana, Liliana Marchetta, Cristina Maria Bonazzi, Andrea Alberto Lissoni, Fabio Landoni, Robert Fruscio
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveImmature teratomas are rare malignant ovarian germ cell tumours, typically diagnosed in young women, where fertility-sparing surgery is the treatment of choice. The role of adjuvant chemotherapy in stage I disease remains controversial. We e
Externí odkaz:
https://doaj.org/article/49229fe9d8184c139625babdf4d1cb60
Autor:
Javier Martin-Broto, Claudia Valverde, Nadia Hindi, Bruno Vincenzi, Javier Martinez-Trufero, Giovanni Grignani, Antoine Italiano, Javier Lavernia, Ana Vallejo, Paolo Dei Tos, Francois Le Loarer, Ricardo Gonzalez-Campora, Rafael Ramos, Diana Hernández-Jover, Antonio Gutierrez, Cesar Serrano, Maria Monteagudo, Rocio Letón, Mercedes Robledo, David S. Moura, Marta Martin-Ruiz, Jose A. López-Guerrero, Julia Cruz, Antonio Fernandez-Serra, Jean-Yves Blay, Elena Fumagalli, Virginia Martinez-Marin
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-8 (2023)
Abstract Background Approximately 15% of adult GIST patients harbor tumors that are wild-type for KIT and PDGFRα genes (KP-wtGIST). These tumors usually have SDH deficiencies, exhibit a more indolent behavior and are resistant to imatinib. Underlyin
Externí odkaz:
https://doaj.org/article/da2ebd0056004ea28583248f6fd4476c
Autor:
Mario Cioce, Maria Rita Fumagalli, Sara Donzelli, Frauke Goeman, Valeria Canu, Daniela Rutigliano, Giulia Orlandi, Andrea Sacconi, Claudio Pulito, Alina Catalina Palcau, Maurizio Fanciulli, Aldo Morrone, Maria Grazia Diodoro, Marco Caricato, Anna Crescenzi, Martina Verri, Vito Michele Fazio, Stefano Zapperi, Massimo Levrero, Sabrina Strano, Gian Luca Grazi, Caterina La Porta, Giovanni Blandino
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-22 (2023)
Abstract Background Approximately 20–50% of patients presenting with localized colorectal cancer progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major prognostic determinant. Here, we have interrogated a het
Externí odkaz:
https://doaj.org/article/a12078091db24f6e823473565b12efbf
Autor:
De la Garza-Ramos C, Montazeri SA, Musto KR, Kapp MD, Lewis AR, Frey G, Paz-Fumagalli R, Ilyas S, Harnois DM, Majeed U, Patel T, Toskich B
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 10, Pp 987-996 (2023)
Cynthia De la Garza-Ramos,1 S Ali Montazeri,1 Kaitlyn R Musto,1 Melissa D Kapp,1 Andrew R Lewis,1 Gregory Frey,1 Ricardo Paz-Fumagalli,1 Sumera Ilyas,2 Denise M Harnois,3 Umair Majeed,4 Tushar Patel,3 Beau Toskich1 1Division of Interventional Radiolo
Externí odkaz:
https://doaj.org/article/36e7b464fc524caebb5972935f4673a7
Autor:
Zuzanna Pelc, Katarzyna Sędłak, Magdalena Leśniewska, Katarzyna Mielniczek, Katarzyna Chawrylak, Magdalena Skórzewska, Tomasz Ciszewski, Joanna Czechowska, Agata Kiszczyńska, Bas P. L. Wijnhoven, Johanna W. Van Sandick, Ines Gockel, Suzanne S. Gisbertz, Guillaume Piessen, Clarisse Eveno, Maria Bencivenga, Giovanni De Manzoni, Gian Luca Baiocchi, Paolo Morgagni, Riccardo Rosati, Uberto Fumagalli Romario, Andrew Davies, Yutaka Endo, Timothy M. Pawlik, Franco Roviello, Christiane Bruns, Wojciech P. Polkowski, Karol Rawicz-Pruszyński
Publikováno v:
Cancers, Vol 16, Iss 9, p 1721 (2024)
The incidence of gastric cancer (GC) is expected to increase to 1.77 million cases by 2040. To improve treatment outcomes, GC patients are increasingly treated with neoadjuvant chemotherapy (NAC) prior to curative-intent resection. Although NAC enhan
Externí odkaz:
https://doaj.org/article/cf604c2325054ab1b0bd15e1a2da7c9f
Autor:
Diletta Fumagalli, Luigi A. De Vitis, Giuseppe Caruso, Tommaso Occhiali, Emilia Palmieri, Benedetto E. Guillot, Giulia Pappalettera, Carrie L. Langstraat, Gretchen E. Glaser, Evelyn A. Reynolds, Robert Fruscio, Fabio Landoni, Andrea Mariani, Tommaso Grassi
Publikováno v:
Cancers, Vol 16, Iss 7, p 1338 (2024)
Endometrial cancer (EC) is the most diagnosed gynecologic malignancy, and its incidence and mortality are increasing. The prognosis is highly dependent on the disease spread. Surgical staging includes retroperitoneal evaluation to detect potential ly
Externí odkaz:
https://doaj.org/article/ad75606712d746ae86151ad89d9c9b8c